Ohio Public Employees Retirement System (OPERS)’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,412
Closed -$173K 2328
2025
Q3
$173K Buy
14,412
+1,100
+8% +$8.79K ﹤0.01% 1701
2025
Q2
$101K Sell
13,312
-8,514
-39% -$51.2K ﹤0.01% 1772
2025
Q1
$120K Buy
21,826
+6,100
+39% +$37.7K ﹤0.01% 1739
2024
Q4
$90.4K Buy
15,726
+8,501
+118% +$81.5K ﹤0.01% 1790
2024
Q3
$74.9K Hold
7,225
﹤0.01% 1683
2024
Q2
$93.7K Sell
7,225
-437
-6% -$5.9K ﹤0.01% 1438
2024
Q1
$134K Sell
7,662
-24,735
-76% -$327K ﹤0.01% 1395
2023
Q4
$305K Buy
32,397
+6,533
+25% +$60.9K ﹤0.01% 1330
2023
Q3
$289K Hold
25,864
﹤0.01% 1313
2023
Q2
$553K Hold
25,864
﹤0.01% 1264
2023
Q1
$1.05M Hold
25,864
﹤0.01% 1151
2022
Q4
$1.2M Sell
25,864
-5,871
-19% -$268K 0.01% 1121
2022
Q3
$1.65M Buy
31,735
+25,237
+388% +$1.47M 0.01% 1097
2022
Q2
$307K Sell
6,498
-8,507
-57% -$462K ﹤0.01% 1414
2022
Q1
$1.07M Buy
15,005
+4,060
+37% +$264K ﹤0.01% 1223
2021
Q4
$818K Buy
10,945
+6,625
+153% +$520K ﹤0.01% 1281
2021
Q3
$245K Hold
4,320
﹤0.01% 1459
2021
Q2
$190K Hold
4,320
﹤0.01% 1529
2021
Q1
$213K Hold
4,320
﹤0.01% 1470
2020
Q4
$182K Hold
4,320
﹤0.01% 1442
2020
Q3
$198K Hold
4,320
﹤0.01% 1349
2020
Q2
$217K Buy
+4,320
New +$224K ﹤0.01% 1365
2019
Q4
Sell
-13,586
Closed -$816K 1893
2019
Q3
$816K Hold
13,586
﹤0.01% 1231
2019
Q2
$1.15M Sell
13,586
-4,015
-23% -$361K 0.01% 1160
2019
Q1
$1.68M Hold
17,601
0.01% 1045
2018
Q4
$1.25M Buy
17,601
+244
+1% +$18.7K 0.01% 1062
2018
Q3
$1.48M Sell
17,357
-2,218
-11% -$222K 0.01% 1118
2018
Q2
$2.27M Buy
19,575
+5,989
+44% +$598K 0.01% 984
2018
Q1
$1.1M Sell
13,586
-5,027
-27% -$387K 0.01% 1229
2017
Q4
$1.09M Sell
18,613
-2,031
-10% -$102K 0.01% 1239
2017
Q3
$966K Hold
20,644
0.01% 1255
2017
Q2
$743K Sell
20,644
-5,336
-21% -$171K ﹤0.01% 1277
2017
Q1
$800K Buy
25,980
+3,625
+16% +$113K ﹤0.01% 1211
2016
Q4
$630K Buy
22,355
+3,146
+16% +$90.2K ﹤0.01% 1260
2016
Q3
$511K Hold
19,209
﹤0.01% 1293
2016
Q2
$424K Buy
19,209
+747
+4% +$19.6K ﹤0.01% 1274
2016
Q1
$542K Buy
18,462
+6,335
+52% +$176K ﹤0.01% 1221
2015
Q4
$400K Buy
12,127
+7,571
+166% +$247K ﹤0.01% 1292
2015
Q3
$165K Buy
+4,556
New +$196K ﹤0.01% 1483

Other funds holding ENTA

Ohio Public Employees Retirement System (OPERS)'s ENTA Position: Q4 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Enanta Pharmaceuticals (ENTA) in Q4 2025, closing a stake of 14,412 shares — an estimated $173K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in ENTA in Q3 2015 and held it in 39 quarters. The position peaked at $2.27M in Q2 2018. 131 funds tracked by Wall St. Rank hold ENTA as of Q4 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Enanta Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 14,412 Enanta Pharmaceuticals shares in Q4 2025, an estimated $173K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 39 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Enanta Pharmaceuticals position peaked at $2.27M in Q2 2018.
  • 131 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2025, filed 17 Feb 2026.